About this Journal Submit a Manuscript Table of Contents

Citations to this Journal [312 citations: 101–200 of 311 articles]

Articles published in Chemotherapy Research and Practice have been cited 312 times. The following is a list of the 311 articles that have cited the articles published in Chemotherapy Research and Practice.

  • Aleksandar Savić, Lana Filipović, Sandra Aranđelović, Biljana Dojčinović, Siniša Radulović, Tibor J. Sabo, and Sanja Grgurić-Šipka, “Synthesis, characterization and cytotoxic activity of novel platinum(II) iodido complexes,” European Journal of Medicinal Chemistry, 2014. View at Publisher · View at Google Scholar
  • Eleonora Turrini, Lorenzo Ferruzzi, and Carmela Fimognari, “Natural compounds to overcome cancer chemoresistance: toxicological and clinical issues,” Expert Opinion on Drug Metabolism & Toxicology, vol. 10, no. 12, pp. 1677–1690, 2014. View at Publisher · View at Google Scholar
  • G. Kenneth Gray, Braden C. McFarland, Susan E. Nozell, and Etty N. Benveniste, “NF-kappa B and STAT3 in glioblastoma: therapeutic targets coming of age,” Expert Review of Neurotherapeutics, vol. 14, no. 11, pp. 1293–1306, 2014. View at Publisher · View at Google Scholar
  • Poonam Sharma, Pawas Goswami, Vikas Sangwan, and Rameshwar Singh, “Antibiotic resistance among commercially available probiotics,” Food Research International, vol. 57, pp. 176–195, 2014. View at Publisher · View at Google Scholar
  • Stephanie Shishido, Halvard Bönig, and Yong-Mi Kim, “Role of Integrin Alpha4 in Drug Resistance of Leukemia,” Frontiers in Oncology, vol. 4, 2014. View at Publisher · View at Google Scholar
  • Zhongbo Hu, and William B. Slayton, “Integrin VLA-5 and FAK are Good Targets to Improve Treatment Response in the Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia,” Frontiers in Oncology, vol. 4, 2014. View at Publisher · View at Google Scholar
  • Sourik S. Ganguly, Xiaohong Li, and Cindy K. Miranti, “The Host Microenvironment Influences Prostate Cancer Invasion, Systemic Spread, Bone Colonization, and Osteoblastic Metastasis,” Frontiers in Oncology, vol. 4, 2014. View at Publisher · View at Google Scholar
  • V. K. Kolli, K. Natarajan, B. Isaac, D. Selvakumar, and P. Abraham, “Mitochondrial dysfunction and respiratory chain defects in a rodent model of methotrexate-induced enteritis,” Human & Experimental Toxicology, vol. 33, no. 10, pp. 1051–1065, 2014. View at Publisher · View at Google Scholar
  • V. M. Patil, S. Chakraborty, P. K. Shenoy, A. Manuprasad, Sajith T. P. Babu, T. Shivkumar, S. Babu, A. Bhatterjee, and S. Balasubramanian, “Tolerance and toxicity of neoadjuvant docetaxel, cisplatin and 5 fluorouracil regimen in technically unresectable oral cancer in resource limited rural based tertiary cancer center,” Indian Journal of Cancer, vol. 51, no. 1, pp. 69–72, 2014. View at Publisher · View at Google Scholar
  • Valeria Ferretti, Marco Fogagnolo, Andrea Marchi, Lorenza Marvelli, Fabio Sforza, and Paola Bergamini, “Acetylcholine-like and Trimethylglycine-like PTA (1,3,5-Triaza-7-phosphaadamantane) Derivatives for the Development of Innovative Ru- and Pt-Based Therapeutic Agents,” Inorganic Chemistry, pp. 140506130435009, 2014. View at Publisher · View at Google Scholar
  • Yasser Elkerm, and Rashad Tawashi, “Date Palm Pollen as a Preventative Intervention in Radiation- and Chemotherapy-Induced Oral Mucositis: A Pilot Study,” Integrative Cancer Therapies, vol. 13, no. 6, pp. 468–472, 2014. View at Publisher · View at Google Scholar
  • Chih-Jung Yao, Tae-Young Han, Ping-Hsiao Shih, Tsu-Yi Yi, I-Chun Lai, Ken-Hu Chang, Tung-Yuan Lai, Chia-Lun Chang, and Gi-Ming Lai, “Elimination of Cancer Stem-Like Side Population in Human Glioblastoma Cells Accompanied With Stemness Gene Suppression by Korean Herbal Recipe MSC500,” Integrative Cancer Therapies, vol. 13, no. 6, pp. 541–554, 2014. View at Publisher · View at Google Scholar
  • Junjun Yang, Yang Xiang, Xirun Wan, Fengzhi Feng, and Tong Ren, “Analysis of the Prognosis and Related Factors for Patients With Stage IV Gestational Trophoblastic Neoplasia,” International Journal of Gynecological Cancer, vol. 24, no. 3, pp. 594–599, 2014. View at Publisher · View at Google Scholar
  • Qing Xia, Yuchen Cai, Roujun Peng, Guosheng Wu, Yanxia Shi, and Wenqi Jiang, “The CDK1 inhibitor RO3306 improves the response of BRCA-proficient breast cancer cells to PARP inhibition,” International Journal of Oncology, vol. 44, no. 3, pp. 735–744, 2014. View at Publisher · View at Google Scholar
  • Koji Harada, Tarannum Ferdous, Hiroaki Kobayashi, and Yoshiya Ueyama, “Paclitaxel in combination with cetuximab exerts antitumor effect by suppressing NF-kappa B activity in human oral squamous cell carcinoma cell lines,” International Journal of Oncology, vol. 45, no. 6, pp. 2439–2445, 2014. View at Publisher · View at Google Scholar
  • Seyedeh Hoda Alavizadeh, Ali Badiee, Shiva Golmohammadzadeh, and Mahmoud Reza Jaafari, “The influence of phospholipid on the physicochemical properties and anti-tumor efficacy of liposomes encapsulating cisplatin in mice bearing C26 colon carcinoma,” International Journal of Pharmaceutics, 2014. View at Publisher · View at Google Scholar
  • Gershon Volpin, Miri Cohen, Michael Assaf, Tamar Meir, Rina Katz, and Shimon Pollack, “Cytokine Levels (IL-4, IL-6, IL-8 and TGFβ) as Potential Biomarkers of Systemic Inflammatory Response in Trauma Patients,” International Orthopaedics, 2014. View at Publisher · View at Google Scholar
  • Anthony Kodzo-Grey Venyo, “Primary Clear Cell Carcinoma of the Urinary Bladder,” International Scholarly Research Notices, vol. 2014, pp. 1–15, 2014. View at Publisher · View at Google Scholar
  • Kimiko Hirata, Takeshi Kodaira, Natsuo Tomita, Yukihiko Ohshima, Junji Ito, Hiroyuki Tachibana, Toru Nakanishi, and Nobukazu Fuwa, “Clinical Efficacy of Alternating Chemoradiotherapy by Conformal Radiotherapy Combined with Intracavitary Brachytherapy for High-risk Cervical Cancer,” Japanese Journal of Clinical Oncology, vol. 44, no. 6, pp. 556–563, 2014. View at Publisher · View at Google Scholar
  • William F. Anderson, Philip S. Rosenberg, and Hormuzd A. Katki, “Tracking and Evaluating Molecular Tumor Markers With Cancer Registry Data: HER2 and Breast Cancer,” Jnci-Journal of The National Cancer Institute, vol. 106, no. 5, 2014. View at Publisher · View at Google Scholar
  • Keith R. Laderoute, Joy M. Calaoagan, Wan-ru Chao, Dominc Dinh, Nicholas Denko, Sarah Duellman, Jessica Kalra, Xiaohe Liu, Ioanna Papandreou, Lidia Sambucetti, and Laszlo G. Boros, “5 '-AMP-activated Protein Kinase (AMPK) Supports the Growth of Aggressive Experimental Human Breast Cancer Tumors,” Journal of Biological Chemistry, vol. 289, no. 33, pp. 22850–22864, 2014. View at Publisher · View at Google Scholar
  • Su-Jin Shin, Gyungyub Gong, Hee Jin Lee, Jun Kang, Young Kyung Bae, Ahwon Lee, Eun Yoon Cho, Ji Shin Lee, Kwang-Sun Suh, Dong Wha Lee, and Woo Hee Jung, “Positive Expression of Insulin-Like Growth Factor-1 Receptor Is Associated with a Positive Hormone Receptor Status and a Favorable Prognosis in Breast Cancer,” Journal of Breast Cancer, vol. 17, no. 2, pp. 113–120, 2014. View at Publisher · View at Google Scholar
  • Shinichi Yamauchi, Satoru Iida, Megumi Ishiguro, Toshiaki Ishikawa, Hiroyuki Uetake, and Kenichi Sugihara, “Clinical Significance of Platelet-Derived Growth Factor-C Expression in Colorectal Cancer,” Journal of Cancer Therapy, vol. 05, no. 01, pp. 11–20, 2014. View at Publisher · View at Google Scholar
  • Li-Fen Hu, Li-Ping Gao, Ying Ye, Xi Chen, Xiang-Tian Zhou, Hai-Fei Yang, Yan-Yan Liiu, Qing Mei, and Jia-Bin Li, “Susceptibility of Stenotrophomonas maltophilia clinical strains in China to antimicrobial combinations,” Journal of Chemotherapy, vol. 26, no. 5, pp. 282–286, 2014. View at Publisher · View at Google Scholar
  • Gabor Valcz, Ferenc Sipos, Zsolt Tulassay, Bela Molnar, and Yukako Yagi, “Importance of carcinoma-associated fibroblast-derived proteins in clinical oncology,” Journal of Clinical Pathology, vol. 67, no. 12, pp. 1026–1031, 2014. View at Publisher · View at Google Scholar
  • Shutao Guo, Lei Miao, Yuhua Wang, and Leaf Huang, “Unmodified drug used as a material to construct nanoparticles: delivery of cisplatin for enhanced anti-cancer therapy,” Journal of Controlled Release, vol. 174, pp. 137–142, 2014. View at Publisher · View at Google Scholar
  • Farshad Homayouni Moghadam, Maryam Dehghan, Ehsan Zarepur, Reyhaneh Dehlavi, Fatemeh Ghaseminia, Shima Ehsani, Golnaz Mohammadzadeh, and Kazem Barzegar, “Oleo gum resin of Ferula assa-foetida L. ameliorates peripheral neuropathy in mice,” Journal of Ethnopharmacology, 2014. View at Publisher · View at Google Scholar
  • L. Soubra, S. Kabbani, M. F. Anwar, and R. Dbouk, “Spectrum and patterns of antimicrobial resistance of uropathogens isolated from a sample of hospitalised Lebanese patients with urinary tract infectio,” Journal Of Global Antimicrobial Resistance, vol. 2, no. 3, pp. 173–178, 2014. View at Publisher · View at Google Scholar
  • Myo Min, Daniel Roos, Elly Keating, Michael Penniment, Scott Carruthers, Lydia Zanchetta, Karen Wong, John Shakeshaft, and Siddhartha Baxi, “External evaluation of the Radiation Therapy Oncology Group brachial plexus contouring protocol: Several issues identified,” Journal of Medical Imaging and Radiation Oncology, vol. 58, no. 3, pp. 360–368, 2014. View at Publisher · View at Google Scholar
  • Jeremy Rees, “Updates in the management of high-grade glioma,” Journal of Neurology, vol. 261, no. 4, pp. 651–654, 2014. View at Publisher · View at Google Scholar
  • Emanuela Binello, Elisabetta Mormone, Luni Emdad, Harini Kothari, and Isabelle M. Germano, “Characterization of fenofibrate-mediated anti-proliferative pro-apoptotic effects on high-grade gliomas and anti-invasive effects on glioma stem cells,” Journal of Neuro-Oncology, 2014. View at Publisher · View at Google Scholar
  • Gordon A. G. McKenzie, Emma E. Hinsley, Keith Hunter, and Daniel W. Lambert, “The endothelin axis in head and neck cancer: a promising therapeutic opportunity?,” Journal of Oral Pathology & Medicine, vol. 43, no. 6, pp. 395–404, 2014. View at Publisher · View at Google Scholar
  • Keita Mizuno, Toru Kono, Yasuyuki Suzuki, Chika Miyagi, Yuji Omiya, Kanako Miyano, Yoshio Kase, and Yasuhito Uezono, “Goshajinkigan, a Traditional Japanese Medicine, Prevents Oxaliplatin-Induced Acute Peripheral Neuropathy by Suppressing Functional Alteration of TRP Channels in Rat,” Journal of Pharmacological Sciences, vol. 125, no. 1, pp. 91–98, 2014. View at Publisher · View at Google Scholar
  • Claire Marie Reyes-Habito, and Ellen K. Roh, “Cutaneous reactions to chemotherapeutic drugs and targeted therapies for cancer Part II. Targeted therapies,” Journal of The American Academy of Dermatology, vol. 71, no. 2, 2014. View at Publisher · View at Google Scholar
  • Guido Cavaletti, “Chemotherapy-induced peripheral neurotoxicity (CIPN): what we need and what we know,” Journal of The Peripheral Nervous System, vol. 19, no. 2, pp. 66–76, 2014. View at Publisher · View at Google Scholar
  • Pushpendra Singh, and Felix Bast, “In silico molecular docking study of natural compounds on wild and mutated epidermal growth factor receptor,” Medicinal Chemistry Research, 2014. View at Publisher · View at Google Scholar
  • Kaifee Arman, Sercan Ergun, Ebru Temiz, and Serdar Oztuzcu, “The interrelationship between HER2 and CASP3/8 with apoptosis in different cancer cell lines,” Molecular Biology Reports, vol. 41, no. 12, pp. 8031–8036, 2014. View at Publisher · View at Google Scholar
  • Noyko S. Stanilov, Iliya A. Karakolev, Tashko S. Deliysky, Jovcho P. Jovchev, and Spaska A. Stanilova, “Association of insulin-like growth factor-I receptor polymorphism with colorectal cancer development,” Molecular Biology Reports, 2014. View at Publisher · View at Google Scholar
  • Ozge Cevik, Hikmet Akpinar, Rabia Oba, Ozlem Tugce Cilingir, Zarife Nigar Ozdemir, Sule Cetinel, and Tevfik Yoldemir, “The effect of Momordica charantia intake on the estrogen receptors ESRα/ESRβ gene levels and apoptosis on uterine tissue in ovariectomy rats,” Molecular Biology Reports, 2014. View at Publisher · View at Google Scholar
  • Jian Ma, Hui Lyu, and Jingcao Huang, “Targeting of erbB3 receptor to overcome resistance in cancer treatment,” Molecular Cancer, vol. 13, 2014. View at Publisher · View at Google Scholar
  • Shikha Gaur, Linling Chen, Vincent Ann, Wei-Chen Lin, Yafan Wang, Vincent H. S. Chang, Nan Yong Hsu, Her-Shuyong Shia, and Yun Yen, “Dovitinib synergizes with oxaliplatin in suppressing cell proliferation and inducing apoptosis in colorectal cancer cells regardless of RAS-RAF mutation status,” Molecular Cancer, vol. 13, 2014. View at Publisher · View at Google Scholar
  • Ning Jiang, Dongsheng Wang, Zhongliang Hu, Hyung Ju C. Shin, Guoqing Qian, Mohammad Aminur Rahman, Hongzheng Zhang, A. R. M. Ruhul Amin, Sreenivas Nannapaneni, Xiaojing Wang, Zhengjia Chen, Gabriela Garcia, Gavin MacBeath, Dong M. Shin, Fadlo R. Khuri, Jun Ma, Zhuo G. Chen, and Nabil F. Saba, “Combination of Anti-HER3 Antibody MM-121/SAR256212 and Cetuximab Inhibits Tumor Growth in Preclinical Models of Head and Neck Squamous Cell Carcinoma,” Molecular Cancer Therapeutics, vol. 13, no. 7, pp. 1826–1836, 2014. View at Publisher · View at Google Scholar
  • Henry D. Reyes, Kristina W. Thiel, Matthew J. Carlson, Xiangbing Meng, Shujie Yang, Jean-Marie Stephan, and Kimberly K. Leslie, “Comprehensive Profiling of EGFR/HER Receptors for Personalized Treatment of Gynecologic Cancers,” Molecular Diagnosis & Therapy, vol. 18, no. 2, pp. 137–151, 2014. View at Publisher · View at Google Scholar
  • Hao Jiang, Peng-Jun Zhao, Dan Su, Jianguo Feng, and Sheng-Lin Ma, “Paris saponin I induces apoptosis via increasing the Bax/Bcl-2 ratio and caspase-3 expression in gefitinib-resistant non-small cell lung cancer in vitro and in vivo,” Molecular Medicine Reports, vol. 9, no. 6, pp. 2265–2272, 2014. View at Publisher · View at Google Scholar
  • R Guabiraba, A G Besnard, G B Menezes, T Secher, M S Jabir, S S Amaral, H Braun, R Cp Lima-Junior, R A Ribeiro, F Q Cunha, M M Teixeira, R Beyaert, G J Graham, and F Y Liew, “IL-33 targeting attenuates intestinal mucositis and enhances effective tumor chemotherapy in mice,” Mucosal Immunology, 2014. View at Publisher · View at Google Scholar
  • Gagan Deep, Rahul Kumar, Anil K. Jain, Chapla Agarwal, and Rajesh Agarwal, “Silibinin inhibits fibronectin induced motility, invasiveness and survival in human prostate carcinoma PC3 cells via targeting integrin signaling,” Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, 2014. View at Publisher · View at Google Scholar
  • Supratim Ghosh, Kamil B. Ucer, Ralph D'Agostino, Ken Grant, Joseph Sirintrapun, Michael J. Thomas, Roy Hantgan, Manish Bharadwaj, and William H. Gmeiner, “Non-covalent assembly of meso-tetra-4-pyridyl porphine with single-stranded DNA to form nano-sized complexes with hydrophobicity-dependent DNA release and anti-tumor activity,” Nanomedicine-Nanotechnology Biology and Medicine, vol. 10, no. 2, pp. 451–461, 2014. View at Publisher · View at Google Scholar
  • Marianna Lucafo, Chiara Pelillo, Marco Carini, Tatiana Da Ros, Maurizio Prato, and Gianni Sava, “A Cationic 60 Fullerene Derivative Reduces Invasion and Migration of HT-29 CRC Cells in Vitro at Dose Free of Significant Effects on Cell Survival,” Nano-Micro Letters, vol. 6, no. 2, pp. 163–168, 2014. View at Publisher · View at Google Scholar
  • Marjo-Riitta Puumalainen, Davor Lessel, Peter Ruethemann, Nina Kaczmarek, Karin Bachmann, Kristijan Ramadan, and Hanspeter Naegeli, “Chromatin retention of DNA damage sensors DDB2 and XPC through loss of p97 segregase causes genotoxicity,” Nature Communications, vol. 5, 2014. View at Publisher · View at Google Scholar
  • Zhao Chen, Christine M. Fillmore, Peter S. Hammerman, Carla F. Kim, and Kwok-Kin Wong, “Non-small-cell lung cancers: a heterogeneous set of diseases,” Nature Reviews Cancer, vol. 14, no. 8, pp. 535–546, 2014. View at Publisher · View at Google Scholar
  • Vladimir P. Torchilin, “Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery,” Nature Reviews Drug Discovery, 2014. View at Publisher · View at Google Scholar
  • Helmout Modjtahedi, Byoung Chul Cho, Martin C. Michel, and Flavio Solca, “A comprehensive review of the preclinical efficacy profile of the ErbB family blocker afatinib in cancer,” Naunyn-Schmiedebergs Archives of Pharmacology, vol. 387, no. 6, pp. 505–521, 2014. View at Publisher · View at Google Scholar
  • Tania E. Schwingel, Caroline P. Klein, Natalia F. Nicoletti, Cristiana L. Dora, Gabriela Hadrich, Cláudia G. Bica, Tiago G. Lopes, Vinicius Duval da Silva, and Fernanda B. Morrone, “Effects of the compounds resveratrol, rutin, quercetin, and quercetin nanoemulsion on oxaliplatin-induced hepatotoxicity and neurotoxicity in mice,” Naunyn-Schmiedeberg's Archives of Pharmacology, 2014. View at Publisher · View at Google Scholar
  • M. Straka, M. Skrovina, R. Soumarova, R. Kotasek, L. Burda, and C. Vojtek, “Up front hepatectomy for metastatic rectal carcinoma - reversed, liver first approach. Early experience with 15 patients,” Neoplasma, vol. 61, no. 4, pp. 447–452, 2014. View at Publisher · View at Google Scholar
  • David E. Piccioni, Julia Selfridge, Reema R. Mody, Reshmi Chowdhury, Sichen Li, Shadi Lalezari, James Wawrzynski, Jennifer Quan, Mira Zurayk, Arthur P. Chou, Desiree E. Sanchez, Linda M. Liau, Benjamin M. Ellingson, Whitney B. Pope, Phioanh L. Nghiemphu, Richard M. Green, He-jing Wang, William H. Yong, Robert Elashoff, Timothy F. Cloughesy, and Albert Lai, “Deferred use of bevacizumab for recurrent glioblastoma is not associated with diminished efficacy,” Neuro-Oncology, vol. 16, no. 6, pp. 815–822, 2014. View at Publisher · View at Google Scholar
  • Senthilvelan Manohar, Samson Jamesdaniel, and Richard Salvi, “Cisplatin Inhibits Hippocampal Cell Proliferation and Alters the Expression of Apoptotic Genes,” Neurotoxicity Research, vol. 25, no. 4, pp. 369–380, 2014. View at Publisher · View at Google Scholar
  • Albert Ale, Jordi Bruna, Xavier Navarro, and Esther Udina, “Neurotoxicity induced by antineoplastic proteasome inhibitors,” Neurotoxicology, vol. 43, pp. 28–35, 2014. View at Publisher · View at Google Scholar
  • Haydar Ali Erken, Emine Rabia Koç, Haşmet Yazıcı, Arzu Yay, Gözde Özge Önder, and Saim Furkan Sarıcı, “Selenium Partially Prevents Cisplatin-Induced Neurotoxicity: A Preliminary Study,” NeuroToxicology, 2014. View at Publisher · View at Google Scholar
  • Kevin Chu Foy, Megan J. Miller, Jay Overholser, Siobhan M. Donnelly, Rita Nahta, and Pravin T.P. Kaumaya, “IGF-1R Peptide Vaccines/ Mimics Inhibit the Growth of BxPC3 and JIMT-1 Cancer Cells in vitro and in vivo and Combined Therapy with HER-1 and HER-2 Peptides Induces Effective Anti-tumor Effects.,” OncoImmunology, pp. 00–00, 2014. View at Publisher · View at Google Scholar
  • Megan Jo Miller, Kevin C Foy, Jay P Overholser, Rita Nahta, and Pravin TP Kaumaya, “HER-3 peptide vaccines/mimics: Combined therapy with IGF-1R, HER-2, and HER-1 peptides induces synergistic antitumor effects against breast and pancreatic cancer cells,” OncoImmunology, pp. e956012, 2014. View at Publisher · View at Google Scholar
  • Yongshan Yao, Shenghan Chen, Xin Zhou, Li Xie, and Aijun Chen, “5-FU and ixabepilone modify the microRNA expression profiles in MDA-MB-453 triple-negative breast cancer cells,” Oncology Letters, vol. 7, no. 2, pp. 541–547, 2014. View at Publisher · View at Google Scholar
  • Fumihiro Yamaguchi, Kunihiko Fukuchi, Yohei Yamazaki, Hiromi Takayasu, Sakiko Tazawa, Hidetsugu Tateno, Eisuke Kato, Aya Wakabayashi, Mami Fujimori, Takuya Iwasaki, Makoto Hayashi, Yutaka Tsuchiya, Jun Yamashita, Norikazu Takeda, and Fumio Kokubu, “Acquired resistance L747S mutation in an epidermal growth factor receptor-tyrosine kinase inhibitor-na ve patient: A report of three cases,” Oncology Letters, vol. 7, no. 2, pp. 357–360, 2014. View at Publisher · View at Google Scholar
  • Jordi Martinez-Serra, Antonio Gutierrez, Saul Munoz-Capo, Maria Navarro-Palou, Teresa Ros, Juan Carlos Amat, Bernardo Lopez, Toni F. Marcus, Laura Fueyo, Angela G. Suquia, Jordi Gines, Francisco Rubio, Rafael Ramos, and Joan Besalduch, “xCELLigence system for real-time label-free monitoring of growth and viability of cell lines from hematological malignancies,” Oncotargets and Therapy, vol. 7, pp. 985–994, 2014. View at Publisher · View at Google Scholar
  • Marta Seretny, Gillian L. Currie, Emily S. Sena, Sabrina Ramnarine, Robin Grant, Malcolm R. MacLeod, Leslie A. Colvin, and Marie Fallon, “Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis,” Pain, vol. 155, no. 12, pp. 2461–2470, 2014. View at Publisher · View at Google Scholar
  • Erika Wissinger, Ingolf Griebsch, Juliane Lungershausen, Talia Foster, and Chris L. Pashos, “The Economic Burden of Head and Neck Cancer: A Systematic Literature Review,” Pharmacoeconomics, vol. 32, no. 9, pp. 865–882, 2014. View at Publisher · View at Google Scholar
  • Christiane R. Maroun, and Tracey Rowlands, “The Met receptor tyrosine kinase: A key player in oncogenesis and drug resistance,” Pharmacology & Therapeutics, vol. 142, no. 3, pp. 316–338, 2014. View at Publisher · View at Google Scholar
  • Carlo Barone, Carmine Pinto, Nicola Normanno, Lorenzo Capussotti, Francesco Cognetti, Alfredo Falcone, and Lorenzo Mantovani, “KRAS Early Testing: Consensus Initiative and Cost-Effectiveness Evaluation for Metastatic Colorectal Patients in an Italian Setting,” Plos One, vol. 9, no. 1, 2014. View at Publisher · View at Google Scholar
  • Farah Khalil, and Scott Antonia, “PD-L1 Expression Is Increased in a Subset of Basal Type Breast Cancer Cells ,” Plos One, vol. 9, no. 2, 2014. View at Publisher · View at Google Scholar
  • Shu-Han Wu, Kuang-Li Lee, Ruei-Hung Weng, Zhao-Xian Zheng, Arthur Chiou, and Pei-Kuen Wei, “Dynamic Monitoring of Mechano-Sensing of Cells by Gold Nanoslit Surface Plasmon Resonance Sensor,” Plos One, vol. 9, no. 2, 2014. View at Publisher · View at Google Scholar
  • Are Hugo Pripp, and Milo Stanisic, “The Correlation between Pro- and Anti-Inflammatory Cytokines in Chronic Subdural Hematoma Patients Assessed with Factor Analysis,” Plos One, vol. 9, no. 2, 2014. View at Publisher · View at Google Scholar
  • Giannis Mountzios, Dimitra Aivazi, Ioannis Kostopoulos, Helen P. Kourea, George Kouvatseas, Eleni Timotheadou, Pantelis Zebekakis, Ioannis Efstratiou, Helen Gogas, Chrisanthi Vamvouka, Sofia Chrisafi, Anastasios Stofas, George Pentheroudakis, Angelos Koutras, Eleni Galani, Dimitrios Bafaloukos, and George Fountzilas, “Differential Expression of the Insulin-Like Growth Factor Receptor among Early Breast Cancer Subtypes,” Plos One, vol. 9, no. 3, 2014. View at Publisher · View at Google Scholar
  • David Bates, Suraj Abraham, Michael Campbell, Ingeborg Zehbe, and Laura Curiel, “Development and Characterization of an Antibody-Labeled Super-Paramagnetic Iron Oxide Contrast Agent Targeting Prostate Cancer Cells for Magnetic Resonance Imaging,” Plos One, vol. 9, no. 5, 2014. View at Publisher · View at Google Scholar
  • Anna Dvorkin-Gheva, and John A. Hassell, “Identification of a Novel Luminal Molecular Subtype of Breast Cancer,” Plos One, vol. 9, no. 7, 2014. View at Publisher · View at Google Scholar
  • Mark R. Kelley, Yanlin Jiang, Chunlu Guo, April Reed, Hongdi Meng, and Michael R. Vasko, “Role of the DNA Base Excision Repair Protein, APE1 in Cisplatin, Oxaliplatin, or Carboplatin Induced Sensory Neuropathy,” Plos One, vol. 9, no. 9, 2014. View at Publisher · View at Google Scholar
  • Iman Habibi, Effat S. Emamian, and Ali Abdi, “Advanced Fault Diagnosis Methods in Molecular Networks,” Plos One, vol. 9, no. 10, 2014. View at Publisher · View at Google Scholar
  • Wensheng Zhang, Andrea Edwards, Erik Flemington, and Kun Zhang, “Somatic Mutations Favorable to Patient Survival Are Predominant in Ovarian Carcinomas,” Plos One, vol. 9, no. 11, 2014. View at Publisher · View at Google Scholar
  • Chi T. Viet, Dongmin Dang, Stacy Achdjian, Yi Ye, Samuel G. Katz, and Brian L. Schmidt, “Decitabine Rescues Cisplatin Resistance in Head and Neck Squamous Cell Carcinoma,” Plos One, vol. 9, no. 11, 2014. View at Publisher · View at Google Scholar
  • Naama Kanarek, Sergei I. Grivennikov, Michael Leshets, Audrey Lasry, Irit Alkalay, Elad Horwitz, Yoav D. Shaul, Matthew Stachler, Elena Voronov, Ron N. Apte, Michele Pagano, Eli Pikarsky, Sankar Ghosh, and Yinon Ben-Neriah, “Critical role for IL-1 beta in DNA damage-induced mucositis,” Proceedings of The National Academy of Sciences of The United States of Ame, vol. 111, no. 6, pp. E702–E711, 2014. View at Publisher · View at Google Scholar
  • Peng Guo, Jing Huang, Liya Wang, Di Jia, Jiang Yang, Deborah A. Dillon, David Zurakowski, Hui Mao, Marsha A. Moses, and Debra T. Auguste, “ICAM-1 as a molecular target for triple negative breast cancer,” Proceedings of The National Academy of Sciences of The United States of Ame, vol. 111, no. 41, pp. 14710–14715, 2014. View at Publisher · View at Google Scholar
  • Koji Taniguchi, and Michael Karin, “IL-6 and related cytokines as the critical lynchpins between inflammation and cancer,” Seminars in Immunology, 2014. View at Publisher · View at Google Scholar
  • Deirdre R. Pachman, James C. Watson, Maryam B. Lustberg, Nina D. Wagner-Johnston, Alexandre Chan, Larry Broadfield, Yin Ting Cheung, Christopher Steer, Dawn J. Storey, Kavita D. Chandwani, Judith Paice, Pascal Jean-Pierre, Jeong Oh, Jayesh Kamath, Marie Fallon, Herwig Strik, Susanne Koeppen, and Charles L. Loprinzi, “Management options for established chemotherapy-induced peripheral neuropathy,” Supportive Care in Cancer, 2014. View at Publisher · View at Google Scholar
  • Stephen Sonis, Linda Elting, Dorothy Keefe, Hoang Nguyen, Steven Grunberg, Pamela Randolph-Jackson, and Michael Brennan, “Unanticipated frequency and consequences of regimen-related diarrhea in patients being treated with radiation or chemoradiation regimens for cancers of the head and neck or lung,” Supportive Care in Cancer, 2014. View at Publisher · View at Google Scholar
  • Mohamed Salah Abdelhamid, Solafa Amin Abdelaziz, Sahar Ali Daoud, Ahmed Mohamed Sadat, Ayman Refaat Abdelhaseeb, Tamer Mohamed Nabil, Mohamed Salah Abdelbasset, Hesham Ahmed Nafady, Khaled Ahmed Shawky, and Mohamed Hasssen Abdelmoola, “Concordance of HER-2/Neu over Expression with Steroid Receptor Status in Female Breast Cancers,” Surgical Science, vol. 05, no. 08, pp. 354–362, 2014. View at Publisher · View at Google Scholar
  • Guang-Ning Yan, Lang Yang, Yang-Fan Lv, Yu Shi, Li-Li Shen, Xiao-Hong Yao, Qiao-Nan Guo, Peng Zhang, You-Hong Cui, Xia Zhang, Xiu-Wu Bian, and De-Yu Guo, “Endothelial cells promote stem-like phenotype of glioma cells through activating the Hedgehog pathway,” The Journal of Pathology, 2014. View at Publisher · View at Google Scholar
  • Sai-Mei Hou, Goran Pershagen, N. Peter Wiklund, Fredrik Nyberg, and Petra J. de Verdier, “The (CCTTT)n microsatellite polymorphism in the NOS2 gene may influence lung cancer risk and long-term survival, especially in non-smokers,” Tumor Biology, vol. 35, no. 5, pp. 4425–4434, 2014. View at Publisher · View at Google Scholar
  • Ming-Ming Tsai, Chia-Siu Wang, Chung-Ying Tsai, Hsiang-Cheng Chi, Yi-Hsin Tseng, and Kwang-Huei Lin, “Potential prognostic, diagnostic and therapeutic markers for human gastric cancer,” World Journal of Gastroenterology, vol. 20, no. 38, pp. 13791–13803, 2014. View at Publisher · View at Google Scholar
  • Theresa M. Allen, and Pieter R. Cullis, “Liposomal drug delivery systems: From concept to clinical applications,” Advanced Drug Delivery Reviews, vol. 65, no. 1, pp. 36–48, 2013. View at Publisher · View at Google Scholar
  • Hardeep S. Oberoi, Natalia V. Nukolova, Alexander V. Kabanov, and Tatiana K. Bronich, “Nanocarriers for delivery of platinum anticancer drugs,” Advanced Drug Delivery Reviews, 2013. View at Publisher · View at Google Scholar
  • Andrew T. Chan, Reiko Nishihara, Charles S. Fuchs, Edward Giovannucci, Teppei Morikawa, Aya Kuchiba, Shuji Ogino, Paul Lochhead, Kaori Shima, Ichiro Kawachi, Zhi Rong Qian, Mai Yamauchi, Xiaoyun Liao, Yu Imamura, and Katsuhiko Nosho, “A Prospective Study of Duration of Smoking Cessation and Colorectal Cancer Risk by Epigenetics-related Tumor Classification,” American Journal Of Epidemiology, vol. 178, no. 1, pp. 84–100, 2013. View at Publisher · View at Google Scholar
  • Harriet Wikman, Markus Glatzel, Burkhard Brandt, Ina Hohensee, Volkmar Mueller, Klaus Pantel, Sabine Riethdorf, Jakob Matschke, Manfred Westphal, Katrin Lamszus, Soenke Meyer-Staeckling, and Isabell Witzel, “Frequent Genetic Alterations in EGFR- and HER2-Driven Pathways in Breast Cancer Brain Metastases,” American Journal Of Pathology, vol. 183, no. 1, pp. 83–95, 2013. View at Publisher · View at Google Scholar
  • Lifu Xiao, Mingjie Tang, Qifei Li, and Anhong Zhou, “Non-invasive detection of biomechanical and biochemical responses of human lung cells to short time chemotherapy exposure using AFM and confocal Raman spectroscopy,” Analytical Methods, vol. 5, no. 4, pp. 874–879, 2013. View at Publisher · View at Google Scholar
  • L. S. Clark, D. L. Hertz, S. Roy, H. L. McLeod, A. A. Motsinger-Reif, E. C. Dees, A. Drobish, and L. A. Carey, “CYP2C8*3 increases risk of neuropathy in breast cancer patients treated with paclitaxel,” Annals Of Oncology, vol. 24, no. 6, pp. 1472–1478, 2013. View at Publisher · View at Google Scholar
  • S. Kim, M. Jary, L. Mansi, B. Benzidane, A. Cazorla, M. Demarchi, T. Nguyen, A. Kaliski, E. Delabrousse, F. Bonnetain, P. Letondal, J. F. Bosset, S. Valmary-Degano, and C. Borg, “DCF (docetaxel, cisplatin and 5-fluorouracil) chemotherapy is a promising treatment for recurrent advanced squamous cell anal carcinoma,” Annals of Oncology, vol. 24, no. 12, pp. 3045–3050, 2013. View at Publisher · View at Google Scholar
  • Antonio Ruggiero, Giovanna Trombatore, Silvia Triarico, Roberta Arena, Pietro Ferrara, Maria Scalzone, Filomena Pierri, and Riccardo Riccardi, “Platinum compounds in children with cancer,” Anti-Cancer Drugs, vol. 24, no. 10, pp. 1007–1019, 2013. View at Publisher · View at Google Scholar
  • Senthilnathan Rajendran, Rajendran Shanmugam Muthupalani, and Arvind Ramanathan, “Lack of RING Finger Domain (RFD) Mutations of the c-Cbl Gene in Oral Squamous Cell Carcinomas in Chennai, India,” Asian Pacific Journal of Cancer Prevention, vol. 14, no. 2, pp. 1073–1075, 2013. View at Publisher · View at Google Scholar
  • Zahra Bahadoran, Zeinab Karimi, Anahita Houshiar-rad, Hamid-Reza Mirzayi, and Bahram Rashidkhani, “Dietary Phytochemical Index and the Risk of Breast Cancer: A Case Control Study in a Population of Iranian Women,” Asian Pacific Journal of Cancer Prevention, vol. 14, no. 5, pp. 2747–2751, 2013. View at Publisher · View at Google Scholar
  • Meltem Demirel Kars, Ufuk Gündüz, Kamil Üney, and Ahmet Levent BaŞ, “Exploring a natural MDR reversal agent: potential of medicinal food supplement Nerium oleander leaf distillate,” Asian Pacific Journal of Tropical Biomedicine, vol. 3, no. 8, pp. 644–649, 2013. View at Publisher · View at Google Scholar
  • Chuchard Punsawad, “Effect of malaria components on blood mononuclear cells involved in immune response,” Asian Pacific Journal of Tropical Biomedicine, vol. 3, no. 9, pp. 751–756, 2013. View at Publisher · View at Google Scholar
  • Takashi Hoshiba, and Masaru Tanaka, “Breast cancer cell behaviors on staged tumorigenesis-mimicking matrices derived from tumor cells at various malignant stages,” Biochemical and Biophysical Research Communications, 2013. View at Publisher · View at Google Scholar
  • Gyoergy Varady, Judit Cserepes, Adrienn Nemeth, Edit Szabo, and Balazs Sarkadi, “Cell surface membrane proteins as personalized biomarkers: where we stand and where we are headed,” Biomarkers in Medicine, vol. 7, no. 5, pp. 803–819, 2013. View at Publisher · View at Google Scholar